What is BeiGene Ltd - ADR Stock Price?

BeiGene Ltd - ADR Stock Price rose 13.37% and outperformed its sector by 17.12% in the past year.

What is BeiGene Ltd - ADR Debt to Equity Ratio?

BeiGene Ltd - ADR Debt to Equity Ratio of 0.32 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is BeiGene Ltd - ADR Return on Equity(ROE)?

BeiGene Ltd - ADR Return on Equity(ROE) for the last financial year was -18.77%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is BeiGene Ltd - ADR Mutual Fund Holding?

BeiGene Ltd - ADR Mutual Fund Holding increased by 0.44% in the last quarter to 26.09.

What is BeiGene Ltd - ADR Promoter Share Holding?

BeiGene Ltd - ADR Promoter Share Holding increased by 0.18% in the most recent quarter to 0.18%.

What is BeiGene Ltd - ADR Institutional Holding?

BeiGene Ltd - ADR Institutional Holding remained the same in the last quarter at 40.45%.

How is the BeiGene Ltd - ADR today?

The BeiGene Ltd - ADR today is trading in the down by -5.05% at 209.41.

How has BeiGene Ltd - ADR performed historically?

The BeiGene Ltd - ADR is currently trading down -5.05% on an intraday basis in the past week the index fell -23.06%. The index has been up 18.05% in the past quarter and rose 13.37% in the past year. You can view this in the overview section.

BeiGene Ltd - ADR XNAS: ONC

BeiGene Ltd - ADR Live Share Price Today, Share Analysis and Chart

Name: BeiGene Ltd - ADR: Is Infosys Ltd. worth buying?
Item: BeiGene Ltd - ADR
Rating: 0.46558325
Author: Trendlyne DVM scores

Download real time

209.41 -11.13 (-5.05%)

27.26% Fall from 52W High

611.4K XNAS Volume

XNAS 08 Apr, 2025 5:30 PM (EDT)

BeiGene Ltd - ADR Key Metrics

My Metrics

Default

Market Capitalization High in industry Unavailable in chosen country	22,557.5
Price to Book High in industry Unavailable in chosen country	6.8
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	40.5
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-7
Rel Perf vs Sector quarter% Unavailable in chosen country	24.9
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-18.8
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-11

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

2.3 / 100

Technically Bearish

16.3 / 100

331

1Yr Price target upside is 58%

23 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Not enough data available

BeiGene Ltd - ADR Stock Price Analysis

Day Price Range -5.0% 1 Day return Unavailable in chosen country	209.4 (LTP) 207.6229.5 LowHigh
Week Price Range -23.1% 1 Week return Unavailable in chosen country	209.4 (LTP) 207.6284.2 LowHigh
Month Price Range -15.2% 1 Month return Unavailable in chosen country	209.4 (LTP) 207.6284.2 LowHigh
52 Week Price Range 13.4% 1 Year return Unavailable in chosen country	209.4 (LTP) 172.7287.9 LowHigh

View full Share Price History

BeiGene Ltd - ADR Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

BeiGene Ltd - ADR's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-6.1

Avg. Estimate

1.7

Low Estimate

-0.1

High Estimate

4.3

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 127.0% in FY25

Consensus Recommendation

23 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 23 analysts for BeiGene Ltd - ADR is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

BeiGene Ltd - ADR Stock Analysis

BeiGene Ltd - ADR stock analysis with key metrics, changes, and trends.

BeiGene Ltd - ADR Metric	VALUE	CHANGE %	TREND	ANALYSIS
Stock Price	$209.41	13.37%	positive	Stock Price rose 13.37% and outperformed its sector by 17.12% in the past year.
Debt to Equity Ratio	0.32	-	positive	Debt to Equity Ratio of 0.32 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-18.77 %	-18.77%	negative	Return on Equity(ROE) for the last financial year was -18.77%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	26.09 %	0.44%	positive	Mutual Fund Holding increased by 0.44% in the last quarter to 26.09.
Promoter Share Holding	0.18 %	0.18%	positive	Promoter Share Holding increased by 0.18% in the most recent quarter to 0.18%.
Institutional Holding	40.45 %	0%	neutral	Institutional Holding remained the same in the last quarter at 40.45%.

VIEW LESS

Loading data..

BeiGene Ltd - ADR - Company Profile

BeiGene Ltd - ADR Management structure

All Gross Remunerations are in USD

Mr. John V. Oyler

Chief Executive Officer and Chairman of the Board

2024

Gross Remuneration

Year

Mr. Aaron Rosenberg

Chief Financial officer

2024

Gross Remuneration

2024

Gross Remuneration

Year

BeiGene Ltd - ADR Live Share Price Today, Share Analysis and Chart

27.26% Fall from 52W High

BeiGene Ltd - ADR Key Metrics

Market Capitalization

Price to Book

Institutional holding current Qtr %

Operating Profit Margin Qtr %

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

Price to Book

Institutional holding current Qtr %

Operating Profit Margin Qtr %

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

BeiGene Ltd - ADR Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

BeiGene Ltd - ADR Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

BeiGene Ltd - ADR's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 127.0% in FY25

Consensus Recommendation

The consensus recommendation from 23 analysts for BeiGene Ltd - ADR is STRONG BUY

BeiGene Ltd - ADR Stock Analysis

BeiGene Ltd - ADR stock analysis with key metrics, changes, and trends.

Stock Price rose 13.37% and outperformed its sector by 17.12% in the past year.

Debt to Equity Ratio of 0.32 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -18.77%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.44% in the last quarter to 26.09.

Promoter Share Holding increased by 0.18% in the most recent quarter to 0.18%.

Institutional Holding remained the same in the last quarter at 40.45%.

BeiGene Ltd - ADR - Company Profile

BeiGene Ltd - ADR Management structure

Mr. John V. Oyler

Chief Executive Officer and Chairman of the Board

Mr. Aaron Rosenberg

Chief Financial officer

BeiGene Ltd - ADR Board of directors

Mr. Anthony C. Hooper

Independent Director

Ms. Shalini Sharp

Director

Dr. Olivier Raymond Brandicourt, M.D.

Director

Mr. John V. Oyler

Chief Executive Officer and Chairman of the Board

Mr. Michael J. Goller

Independent Director

Mr. Ranjeev Krishana

Lead Independent Director

BeiGene Ltd - ADR FAQ

How is BeiGene Ltd - ADR today?

BeiGene Ltd - ADR today is trading in the red, and is down by -5.05% at 209.41.

How has BeiGene Ltd - ADR performed historically?

BeiGene Ltd - ADR is currently trading down -5.05% on an intraday basis. In the past week the stock fell -23.06%. stock has been up 18.05% in the past quarter and rose 13.37% in the past year. You can view this in the overview section.